EGFR and lung adenocarcinoma: Using transcriptome data from lung adenocarcinomas that monitor expression levels of genes that play important and specific roles in glucose metabolism, we investigated possible correlations between the standardized uptake value (SUV) of 18F-FDG PET and EGFR or KRAS mutation status in lung adenocarcinoma.